These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 10636127)

  • 21. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.
    Wanschitz JV; Dubourg O; Lacene E; Fischer MB; Höftberger R; Budka H; Romero NB; Eymard B; Herson S; Butler-Browne GS; Voit T; Benveniste O
    Neuromuscul Disord; 2013 Jan; 23(1):75-83. PubMed ID: 23058947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of granulysin in polymyositis and inclusion-body myositis.
    Ikezoe K; Ohshima S; Osoegawa M; Tanaka M; Ogawa K; Nagata K; Kira JI
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1187-90. PubMed ID: 16980658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
    Sugiura T; Murakawa Y; Nagai A; Kondo M; Kobayashi S
    Arthritis Rheum; 1999 Feb; 42(2):291-8. PubMed ID: 10025923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
    Vattemi G; Engel WK; McFerrin J; Askanas V
    J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
    Amemiya K; Granger RP; Dalakas MC
    Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
    Suárez-Calvet X; Gallardo E; Nogales-Gadea G; Querol L; Navas M; Díaz-Manera J; Rojas-Garcia R; Illa I
    J Pathol; 2014 Jul; 233(3):258-68. PubMed ID: 24604766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis.
    Li M; Dalakas MC
    Neurology; 2000 Apr; 54(8):1665-70. PubMed ID: 10762511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in transglutaminase 2 in idiopathic inflammatory myopathies.
    Choi YC; Kim TS; Kim SY
    Eur Neurol; 2004; 51(1):10-4. PubMed ID: 14631123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A; Daniels BH; Margeta M
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
    Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
    Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemokines in idiopathic inflammatory myopathies.
    De Paepe B; Creus KK; De Bleecker JL
    Front Biosci; 2008 Jan; 13():2548-77. PubMed ID: 17981734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in the role of cytokines and chemokines in inflammatory myopathies.
    Lundberg IE; Nyberg P
    Curr Opin Rheumatol; 1998 Nov; 10(6):521-9. PubMed ID: 9812212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis.
    Dalakas MC; Sivakumar K
    Curr Opin Neurol; 1996 Jun; 9(3):235-9. PubMed ID: 8839618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory muscle diseases.
    Mastaglia FL
    Neurol India; 2008; 56(3):263-70. PubMed ID: 18974552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles.
    Tsuruta Y; Furuta A; Taniguchi N; Yamada T; Kira J; Iwaki T
    Acta Neuropathol; 2002 Jan; 103(1):59-65. PubMed ID: 11837748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.